Eurosets, an Italian manufacturing company, quadruples the production of ECMO devices to face the Coronavirus global health emergency.

This goal has been achieved thanks to the sense of responsibility of our employees – says Antonio Petralia, Chief Executive Officer at Eurosets -. Our priority is to supply the Italian hospitals.

Read the article by Il Sole 24 Ore.

The sustainable development is not possible without sustainable energy.

Our priorities are: maximize the productivity of resources, energy efficiency and minimize waste. We have taken an sustainable-oriented approach that underpins everything we do.

We have made intentional changes to the company culture in order to serve our planet because our planet our responsibility.

In line with the Sustainable Development Goals of United States, Eurosets has consequently made significant efforts in opting for eco-friendly solutions, from optimized energy consuption and using plastic free packaging whenever possible.

Each action is aimed at reduce Eurosets carbon footprint.

The trigeneration plant installed in 2019 allows us to produces thermal energy that, when properly transferred, can partly provide heating for the factory and partly power a heat-exchanger to produce cold water.

Thanks to innovative solutions in terms of energy production, we reach an 83% of energy autonomy.

Starting from 2019 the new cardboard eco-packaging is mainly made of already recycled material and 100% recyclable.

Thanks to this new eco-solution, we trasform the 48% of PTS packaging from plastic tray to cardboard tray! This means that, since the beginning of this project we have saved 48% of the total amount of plastic used, the equivalent of 58 tons of plastic and 410.102 tons of CO2.

Eurosets facility has been designed and built considering the energy saving and the reduction of the environmental impacts. The company is equipped by:

• Photovoltaic system for electricity production from renewable sources;
• Hanging gardens to naturally insulate the facility;
  Interior gardens that allow for an optimum level of daylight every day;
• LED lighting powered by solar panels.

Medolla (Italy), January 2021 – Eurosets, a leader in the development, production and commercialization of advanced medical devices, announces the full commercial release (out of USA) of its novel ECMOlife system for ExtraCorporeal Life Support (ECLS). This release comes after a successful pre-market clinical evaluation in which critically ill patients were supported by the device for a cumulative period of over 400 days with the longest individual treatment lasting 27 days.

ECMOlife expands Eurosets’ portfolio to provide temporary support to patients in different therapeutic areas, including ExtraCorporeal Membrane Oxygenation (ECMO) and Mechanical Circulatory Support (MCS). These therapies are used to treat patients suffering from ventricular disease, cardiac arrest or respiratory failure resulting from acute respiratory distress syndrome (ARDS), H1N1, SARS, or COVID-19 infections.

ECMOLife is a life-saving device that is able to temporarily replace the functions of severely compromised heart and lungs. The device acts as an external artificial organ connected to the patient through the main blood vessels and is used in cases where pharmacological therapy is considered insufficient.

Featuring a magnetic-levitating centrifugal pump, optimal performance and enhanced biocompatibility, ECMOlife is the most gentle, safe and versatile solution for ECLS. It is also the only device available on the market with an integrated backup system, ensuring greater patient safety and easier management for healthcare professionals even during extra-hospital transports.

ECMOlife underwent a pre-market evaluation across nine centers in Europe. The device was adopted for treatment of critically ill Covid-19 patients when mechanical ventilation was unsuccessful, as well as patients suffering from post-cardiotomy cardiogenic shock, undergoing lung transplant or requiring cardiopulmonary assistance.

One of the first centers to use ECMOlife was the University Hospital of Brussels. The ECLS team, led by Prof. Dr. Meir, Head of Cardiac Surgery, Prof. Dr. De Waele, Head of the ICU and Dr. Kurt Staessens, Head of the Cardiovascular Perfusion Group, reported about their experience:

“We are really pleased with the performance of ECMOLife. The magnetic levitation technology can reduce the level of hemolysis and the risk of thrombus generation. In addition, the non-invasive monitoring system combined with the unique integrated backup unit may improve patient care, ensuring additional safety in the event of an emergency”.

“Our mission is to offer new solutions to patients who do not benefit from traditional therapies and ECMOLife is fully in line with these core beliefs”

said Antonio Petralia, Executive Vice President & CEO of Eurosets.

“Our device supported critically ill patients for 6 months since its pre-market clinical evaluation release in Europe and we are now very proud to have it fully available to help patients and clinicians worldwide.”

DISCOVER ECMOlife

The company of the biomedical district joins the initiative “Medolla Cardioprotetta” with the aim of a widespread distribution of “life-saving” devices in case of emergencies

Medolla (MO), February 26, 2021 – Eurosets, an Italian company from Medolla (MO) specializing in the design, production and distribution of biomedical devices, has joined the “Medolla Cardioprotetta” project with the aim of raising funds for the purchase and installation of defibrillators (AED) in public places, including schools.

Eurosets has contributed with the donation of 10 defibrillators (AED): it was held today the delivery of the devices in the presence of the mayor of Medolla Alberto Calciolari, the deputy mayor Graziella Zacchini and the president of Consulta of Medolla Lucio De Biaggi.

said the mayor of Medolla, Alberto Calciolari

The initiative, launched in November 2019 by the municipality of Medolla, materialized through the diffusion on the territory of defibrillators, “life-saving” devices.

comments Dr. Elisa Mikus, cardiac surgeon at Maria Cecilia Hospital in Cotignola (RA). The widespread diffusion on the territory will certainly give positive results in the prompt management of patients in emergency. This is also confirmed by the territorial managers of 118:

The devices donated by Eurosets and by the supporters of the initiative will be installed in the next few days and a map with their dislocation will also be drawn up. As for training, the Blue Cross is already organizing courses on the proper use of defibrillators, which can be accessed by all interested people.

“In Italy, it is estimated that there are more than 60,000 people affected by cardiac arrest every year -comments Antonio Petralia, Vice President and CEO of Eurosets -

The survival rate of these people rises from 5% to 30% thanks to the intervention with the defibrillators (AED) present in the territory. We are proud to be able to offer our contribution in this important project strongly promoted by the municipal administration. This initiative is part of the project of Eurosets, to invest more in the field of social sustainability and in particular in aspects related to health, because health should not be seen as a cost but is an investment for the whole community and therefore must be guarded.”